Visit CURE at http://curenet.org and CURE BioScience Explorations at http://bioscienceexplorations.org

Feb 2011

 



Events Column
 
2/16 4:00 pm - 6:00 pm
CURE/Yale BioHaven presents Novatract Surgical. Anlyan Center, 300 Cedar Street, New Haven. more
 
3/1 4:00 pm
Nominations due for Connecticut Medal of Science. more
3/2 4:00 pm - 6:00 pm
CURE/Yale BioHaven presents Axerion. Anlyan Center, 300 Cedar Street, New Haven. more
3/22 7:45 am - 5:30 pm
StemConn2011 scientific symposium. Register now! Marriott Hotel, Farmington. more
 

Life sciences draws over 1/3 of CT 2010 venture capital

Fourth quarter 2010 venture capital investments in the Connecticut life sciences sector included $2.5 million in Helix Therapeutics and $1.2 million in Affinimark Technologies. The sector drew more than a third of all new venture capital invested in Connecticut in 2010, according to The MoneyTree® Report, issued quarterly by PricewaterhouseCoopers and the National Venture Capital Association, based on data from Thomson Reuters.

Details are as follows.

CT Life Science Venture Capital Investments: Representative Investments by Quarter and Type

 

 

Company

$
2010 Biotechnology Q4 Helix Therapeutics 2,500,000
2010 Medical Devices Q4 Affinimark Technologies 1,247,000
2010 Biotechnology Q3 Cara Therapeutics 15,000,000
2010 Biotechnology Q3 Ikonisys 3,804,900
2010 Medical Devices Q3 Affinimark Technologies 425,000
2010 Biotechnology Q3 Metagenomix 257,000
2010 Medical Devices Q3 Advanced Orthopedic Technologies 50,000
2010 Medical Devices Q2 EipEp 1,500,000
2010 Medical Devices Q2 Soft Tissue Regeneration 3,500,000
2010 Biotech Q2 BioRelix 552,000
2010 Biotech Q2 Metagenomix 700,000
2010 Biotech Q2 Cytogel Pharma 2,200,000
2010 Biotech Q2 Mira Dx 4,000,000
2010 Biotech Q2 CyVek 4,013,000
2010 Biotech Q1 Metagenomix 400,000
2010 Biotech Q1 FMP Products 500,000
2010 Biotech Q1 Axerion Therapeutics 750,000
2010 Biotech Q1 Kolltan Pharmaceuticals 10,000,000
2010 Other Q1 Ion Torrent Systems 10,000,000
       
2009 Medical Devices Q4 HistoRx 3,161,000
2009 Biotech Q4 Rib-X 5,284,000
2009 Biotech Q4 Affomix 1,854,000
2009 Biotech Q3 Kolltan 5,000,000
2009 Biotech Q3 BioRelix 3,600,000
2009 Biotech Q2 Marinus 20,412,000
2009 Biotech Q1 Rib-X Pharmaceuticals 25,000,200
2009 Biotech Q1 Affomix Corporation 5,211,000
2009 Biotech Q1 Optherion, Inc. 5,000,000
       
2008 Medical Devices Q4 SurgiQuest, Inc.

9,500,000

2008 Medical Devices Q4 Carigent Therapeutics, Inc.

600,000

2008 Biotechnology Q3 Cara Therapeutics, Inc.

12,300,000

2008 Biotech Q2 Optherion, Inc.

15,000,000

2008 Medical Devices Q2 SurgiQuest, Inc.

4,750,000

2008 Biotech

Q1

Pequot EnzymeRx

14,000,000

2008 Biotech

Q1

Affomix

7,000,000
       

2007 Biotech

Q1

RainDance Technologies

23,655,000

2007 Biotech

Q1

Cara Therapeutics

5,000,000

2007 Biotech

Q2

Spine Wave

45,000,200

2007 Biotech

Q2

BioRelix

25,750,200

2007 Biotech

Q3

Optherion

10,000,000

2007 Biotech

Q3

Genomas

2,500,000

2007 Biotech

Q3

REN Pharmaceuticals

1,000,000

2007 Biotech

Q4

Optherion

26,999,700

2007 Biotech

Q4

Carigent Therapeutics

2,000,000

 

 

 

 

2007 Medical Devices

Q1

Stevens Proof of Concept

500,000

2007 Medical Devices

Q1

Applied Spine Technologies

15,000,000

2007 Medical Devices

Q2

Applied Spine Technologies

13,000,000

2007 Medical Devices

Q3

HistoRx

6,552,000

2007 Medical Devices

Q4

Ikonisys

20,000,000

2007 Medical Devices

Q4

HistoRx

2,280,000

CT Life Science Venture Capital Investments by Type

 

2006

2007

2008

 

Deals

$

Deals

$

Deals

$

Biotech

9

146,600,800

9

145,589,300

4

24,300,400

Medical Devices

2

15,000,000

7

69,332,000

5

19,387,000

Other*

     1 23,655,000    

TOTAL (Life Sciences)

11

161,600,800

17

238,576,300

9

43,687,400

* RainDance Technologies of Guilford

CT Life Science Venture Capital Investments by Type (cont.)

 

2009

2010

 

Deals

$

Deals

$

Biotech

10

106,861,200

 14 57,272,900

Medical Devices

5

4,211,000

 6 6,347,000
Other*     1 10,000,000

TOTAL (Life Sciences)

15

111,072,200

 20 73,619,900

CT Life Science Venture Capital Investments by Type (cont.)

 

Q1 2010

Q2 2010

 

Deals

$

Deals

$

Biotech

4

24,246,000

5

11,465,000

Medical Devices

0

0

3

5,050,000

Other*

1

10,000,000

 

 

TOTAL (Life Sciences)

5

34,246,000

8

16,515,000

 

Q3 2010

Q4 2010

 

Deals

$

Deals

$

Biotech

4

19,061,900

1

2,500,000

Medical Devices

1

50,000

1

1,247,000

Other*

 

 

 

 

TOTAL (Life Sciences)

5

19,111,900

2

3,747,000

*Ion Torrent Systems of Guilford

CT Venture Capital Investments by Quarter


Quarter


# of Deals

Investment Amount

Life Sciences Amount


% Life Sciences
Q4 2010 9 $12.5 million $3.7 million 29.6%
Q3 2010 14 $34.0 million $19.1 million 56.2%
Q2 2010 16 $24.6 million $16.5 million 67.1%
Q1 2010 13 $129.1 million $34.2 million 26.5%
Note: Q1 2010 Total Investment Amount includes a single deal in Financial Services of $85.8 million (Pierpont Securities). Excluding that one deal, the relative investments would be:
Q1 2010 14 $41.6 million $21.7 million 52%
Q4 2009 11 $18.8 million $10.3 million

55%

Q3 2009 10 $14.7 million $6.0 million

41%

Q2 2009 11 $48.4 million $21.2 million

44%

Q1 2009 6 $72.3 million $70.2 million

97%

Q4 2008 9 $15.1 million $10.1 million

67%

Q3 2008 11 $50.6 million $12.3 million

24%

Q2 2008 8 $31.5 million $10.7 million

34%

Q1 2008 8 $18.1 million

$7.0 million

39%
Q4 2007 13

$78.1 million

$61.3 million

81%
Q3 2007 9

$36.8 million

$19.1 million

52%
Q2 2007 9

$107.1 million

$88.5 million

83%
Q1 2007 7

$ 51.7  million

$46.0 million

89%
Q4 2006 6

$39.3 million

$20.1 million

52%

Q3 2006

10

$56.4 million

$21.5 million

38%

Q2 2006

9

$111.7 million

$68.7 million

62%

Q1 2006

6

$56.6 million

$51.3 million

91%

CT Venture Capital Investments by Year


Year


#  of Deals

Investment Amount

Life Sciences Amount


% Life Sciences
2010 52

$200.1 million

$73.6 million 37%
2009 39

$157.4 million

$111.1 million 71%
2008

37

$121.2 million

$43.7 million 36%
2007

37

$273.7 million

 $214.9 million 79%
2006

31

$263.9 million

 $161.6 million 61%

2005

31

$192.8 million

    

2004

32

$195.9 million

    

2003

34

$203.8 million

    

2002

38

$182.7 million

    
2001

70

$549.8 million

    
 
 
Copyright 2010 © Connecticut United for Research Excellence. All rights reserved. Visit CURE at http://curenet.org and CURE BioScience Explorations at http://bioscienceexplorations.org
Click here for Archive of back issues.
Newsletter developed and edited by HarveyMalis Communications LLC, Guilford, Conn.

Managing Your Subscriptions
Click on the "Manage your subscription" link below and then on "Edit Your Profile." To subscribe to a publication, type a "y" in the box to the right of the publication name. To unsubscribe, leave the box blank.